ResMed said its annual meeting of stockholders was held on November 20, 2024, where stockholders elected 11 directors, ratified KPMG LLP as the independent auditor, and approved on an advisory basis the compensation of named executive officers (say-on-pay).

1. 01

   ResMed said its annual meeting of stockholders was held on November 20, 2024, where stockholders elected 11 directors, ratified KPMG LLP as the independent auditor, and approved on an advisory basis the compensation of named executive officers (say-on-pay).

2. 02

   The company said 11 director nominees were elected. Richard Sulpizio received 88,007,747 votes for and 22,003,356 against, and Ronald Taylor received 95,465,730 votes for and 14,705,330 against.

3. 03

   The company said the vote to select KPMG LLP as independent registered public accounting firm for the fiscal year ended June 30, 2025 received 105,082,628 votes for, 10,096,722 against and 47,249 abstentions.

4. 04

   The company said the advisory say-on-pay vote on named executive officer compensation recorded 92,885,004 votes for, 17,284,647 against, 87,620 abstentions and 4,969,328 broker non-votes.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.